Want to see JP:3671 full AI Analyst Report?
3671 Stock Chart & Stats
¥334.00
¥0.00(0.00%)
At close: 4:00 PM EST
¥334.00
¥0.00(0.00%)
Day’s Range― - ―
52-Week Range¥270.00 - ¥416.00
Previous CloseN/A
Volume5.20K
Average Volume (3M)27.38K
Market Cap
¥6.61B
Enterprise Value¥6.62B
Total Cash (Recent Filing)¥2.77B
Total Debt (Recent Filing)¥2.44B
Price to Earnings (P/E)12.8
Beta0.56
Next Earnings
Nov 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.64%
Share Statistics
EPS (TTM)21.54
Shares Outstanding24,050,800
10 Day Avg. Volume37,000
30 Day Avg. Volume27,383
Financial Highlights & Ratios
PEG Ratio0.73
Price to Book (P/B)2.04
Price to Sales (P/S)1.16
P/FCF Ratio20.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Stable ProfitabilityThe company has maintained solid profitability across several years, indicating that its healthcare software and services model can generate earnings despite changing annual revenue levels. Sustained net and EBIT margins provide internal funding capacity and support resilience over the next several quarters.
High Free Cash Flow ConversionFree cash flow closely tracking net income suggests reported profits have generally translated into cash rather than remaining tied up in accounting items. This supports the company’s ability to fund operations, maintain systems, and potentially return capital without relying entirely on external financing.
Healthcare IT Revenue ModelThe business combines upfront deployment revenue with post-launch maintenance and support services for medical institutions. That installed-base model can deepen customer relationships and create continuing service opportunities, giving revenue a more durable foundation than one-time software sales alone.
Bears Say
Sharp Revenue ContractionA 22% annual revenue decline represents a material setback in demand or project delivery and weakens the near-term growth profile. If the contraction persists, lower scale could reduce operating leverage, constrain reinvestment, and make it harder to sustain the company’s historical profitability.
Gross Margin CompressionThe decline in gross margin indicates that the latest revenue base generated less profit before operating expenses. Continued pressure would reduce the earnings benefit from each implementation or service contract and could challenge the company’s ability to preserve its historically steady net and EBIT margins.
Higher Leverage And Weaker Cash FlowHigher leverage increases financial exposure while weaker operating cash flow reduces the internally generated funds available for investment and obligations. Together, these changes leave less flexibility if earnings remain volatile, particularly after the latest year’s revenue decline and margin deterioration.
3671 FAQ
What was Softmax Co., Ltd. (Japan)’s price range in the past 12 months?
Softmax Co., Ltd. (Japan) lowest stock price was ¥270.00 and its highest was ¥416.00 in the past 12 months.
What is Softmax Co., Ltd. (Japan)’s market cap?
Softmax Co., Ltd. (Japan)’s market cap is ¥6.61B.
When is Softmax Co., Ltd. (Japan)’s upcoming earnings report date?
Softmax Co., Ltd. (Japan)’s upcoming earnings report date is Nov 10, 2026 which is in 14 days.
How were Softmax Co., Ltd. (Japan)’s earnings last quarter?
Softmax Co., Ltd. (Japan) released its earnings results on Aug 12, 2026. The company reported ¥3.36 earnings per share for the quarter.
Is Softmax Co., Ltd. (Japan) overvalued?
According to Wall Street analysts Softmax Co., Ltd. (Japan)’s price is currently Overvalued.
Does Softmax Co., Ltd. (Japan) pay dividends?
Softmax Co., Ltd. (Japan) pays a Annually dividend of ¥10 which represents an annual dividend yield of 3.64%. See more information on Softmax Co., Ltd. (Japan) dividends here
What is Softmax Co., Ltd. (Japan)’s EPS estimate?
Softmax Co., Ltd. (Japan)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Softmax Co., Ltd. (Japan) have?
Softmax Co., Ltd. (Japan) has 24,050,800 shares outstanding.
What happened to Softmax Co., Ltd. (Japan)’s price movement after its last earnings report?
Softmax Co., Ltd. (Japan) reported an EPS of ¥3.36 in its last earnings report. Following the earnings report the stock price went up 1.948%.
Which hedge fund is a major shareholder of Softmax Co., Ltd. (Japan)?
Currently, no hedge funds are holding shares in JP:3671
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Softmax Co., Ltd. (Japan)
Softmax Co., Ltd handles the complete spectrum of corporate system services, encompassing their development, commercialization, deployment, and ongoing support. A significant portion of their work is dedicated to creating advanced medical information systems. Their offerings within the healthcare sector are diverse, comprising web-based electronic medical record (EMR) systems, online patient ordering platforms, medical financial management software, radiology information systems, and specialized solutions for rehabilitation departments, health screening, nursing task management, and surgical units. Established in 1974, Softmax Co., Ltd's corporate headquarters are located in Tokyo, Japan.